GL1X · GenesisL1 explorer

MolNFT v1 · #143251 · protein

Structure of cetuximab with aminoheptanoic acid-linked N-butylarginine meditope variant

6AU5: “Structure of cetuximab with aminoheptanoic acid-linked N-butylarginine meditope variant”. X-ray diffraction, 1 ligand (SO4). MolNFT v1 #143251 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6AU5
Type
protein
Length
885 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P01834, S6B291
Ligands
SO4

Structure

x-ray diffraction · 4 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein212—P01834
B, D—protein220—S6B291
C—protein213—P01834
E, F—protein10——

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 3 copies · chains B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6AU5 · Structure of cetuximab with aminoheptanoic acid-linked n-butylarginine meditope variant · the same entry in another collection · chain F against F, TM-score 1.00
  • P01834 · AlphaFold monomer V2.0 prediction for immunoglobulin kappa constant (P01834) · a predicted model of the same protein · chain C against A, TM-score 0.50

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.